Welcome to our dedicated page for Cbd Life Science news (Ticker: CBDL), a resource for investors and traders seeking the latest updates and insights on Cbd Life Science stock.
CBD Life Sciences Inc. develops and distributes CBD, hemp-derived and wellness products through its flagship brand, The CBD Vault. The company's announcements cover product launches across therapeutic topicals, transdermal CBD patches, nicotine-free CBD pouches, edibles, functional mushroom supplements, nutraceutical powders, alkaline CBD functional water, and animal wellness products.
Recurring updates also address retail, wholesale, and online distribution, including specialty retail and dispensary placements, as well as brand expansion under wholly owned subsidiaries Mushroom Madness Inc. and Formrunner Apparel. The company links new formulations and distribution relationships to its broader CBD and functional wellness portfolio.
CBD Life Sciences, Inc. (OTC PINK:CBDL) has signed a Memorandum of Understanding (MOU) to acquire a 45% ownership interest in a state-licensed Cannabis Dispensary in New York. The targeted acquisition has an estimated business value of $10 million with projected 2024 gross revenues of up to $4.5 million. The dispensary, expected to be located on Long Island, is positioned to become a key revenue generator for CBDL.
This strategic move aligns with CBDL's commitment to growth and expanding its footprint in the Northeast region. The company will be entitled to a share of the monthly profits from the dispensary's operations, subject to necessary approvals and finalization of a formal agreement. CEO Lisa Nelson expressed confidence that this endeavor will drive considerable revenue growth and reinforce CBDL's leadership in the industry.
CBD Life Sciences (OTC PINK:CBDL) is in advanced discussions to acquire a strategic minority interest in two state-licensed cannabis dispensaries in Upstate New York and Long Island. The targeted acquisitions have an estimated business value of $14 million. The Upstate New York dispensary is projected to open by November 1, 2024, with the Long Island location following in early 2025.
This strategic move aims to capture a share of New York's legal cannabis market, expected to exceed $4.2 billion by 2027. The company anticipates a 20% increase in annual revenue by the end of the first year of operations and a 15% increase in EBITDA following the dispensary openings. This expansion aligns with CBDL's growth strategy, focusing on key markets, revenue growth, and enhanced profitability.
The CBD Vault, a subsidiary of CBD Life Sciences Inc. (CBDL), is exploring distribution and joint venture opportunities in China following new CBD regulations effective September 1st. The USDA memo indicates that CBD is now integrated into China's 'precursor chemicals management system', allowing for nationwide production and marketing with proper applications. This expands beyond previous limitations to Yunnan and Heilongjiang provinces.
Lisa Nelson, President & CEO of CBDL, sees this as an opportune time to strike deals in China's CBD sector. The company is actively working with wholesalers, distributors, retailers, and merchant banks to locate new business opportunities. The CBD Vault offers a full line of cannabidiol-based and organic products, including Delta 8 & 10 Gummy's, tinctures, pain creams, and pet products, available on their website www.thecbdvault.com.
CBD Life Sciences Inc. (OTC PINK:CBDL) and its subsidiary, The CBD Vault Inc., have signed a partnership agreement with the Vienna Vikings, a premier football team in the European League of Football. The Vikings, currently 11-0 with an average attendance of 20,000+ per game, will use CBD Vault's pain relief and roll-on hemp cream for player recovery. This partnership offers significant global brand exposure for CBD Vault.
Key figures from the Vikings, including quarterback Ben Homes and director Lenard Oberladstatter, have praised the effectiveness of CBD Vault's products. Lisa Nelson, CEO of CBDL, emphasized that this partnership is a pivotal moment for expanding exposure and revenue globally, marking the beginning of a series of groundbreaking collaborations aimed at market dominance.
CBD Life Sciences Inc. (OTC PINK:CBDL) welcomes the Harris-Walz presidential ticket's endorsement of cannabis legalization, marking the first time a major U.S. presidential ticket has openly supported federal cannabis legalization. This political shift could significantly impact the cannabis and CBD industries, potentially leading to:
- A more regulated and transparent market
- Greater opportunities for innovation
- Expanded market access
- Enhanced research and development
- More refined products and clearer guidelines for consumers
CBDL's CEO, Lisa Nelson, expressed enthusiasm for the potential benefits this could bring to the industry and the company, aligning with CBDL's mission to deliver premium CBD products.
CBD Life Sciences Inc. (OTC PINK:CBDL) has signed a Memorandum of Understanding (MOU) with a large mushroom supplement company. This partnership aims to expand CBDL's revenue opportunities beyond CBD into the adaptogenic mushroom market. Adaptogenic mushrooms are known for potentially helping the body respond to stress, anxiety, fatigue, and overall well-being, without psychoactive effects.
The CBD Vault Inc., a wholly-owned subsidiary of CBDL, offers a full line of cannabidiol-based and organic products, including Delta 8 & 10 Gummy's, Full Spectrum Tinctures & Gummy's, Pain Cream, and various other CBD-infused items. These products are available for retail and wholesale purchase through the company's website, www.thecbdvault.com.
CBD Life Sciences Inc. (OTC PINK:CBDL) has announced an expansion into Sedona, Arizona, a major tourist destination with approximately 3 million annual visitors. This move is expected to drive revenue growth and increase brand exposure. The company's products will be available in various local establishments, including:
- Vape stores
- Spas
- Holistic stores
- Nail salons
- Pet shops (offering pet treats)
CBDL also stated that it has no plans for future reverse splits and is focusing on organic revenue growth. The company hinted at upcoming international partnerships and the possibility of reducing authorized share count or buying back shares if market conditions are favorable.
CBD Life Sciences Inc. (OTC PINK:CBDL) has announced an increased revenue projection for 2025, forecasting $1.8 million in sales for its CBD Vault™ brand. This upward revision is attributed to anticipated organic growth and expected revenue contributions from recently added sales channel partners. The company is also exploring opportunities to establish operating partnerships on a more national scale.
Lisa Nelson, CEO of CBDL, expressed satisfaction with the reception of the CBD Vault™ brand, noting its role in gaining traction and visibility in the competitive CBD products market. The company aims to leverage this increased visibility to secure stronger sales channel partners, which will drive future sales objectives.
CBD Life Sciences Inc. (OTC PINK:CBDL) has increased its 2025 revenue projection to $1.8 million for its CBD VaultTM brand sales. This forecast is based on anticipated organic growth and expected revenue from recently added sales channel partners. The company is also exploring opportunities to establish operating partnerships on a national scale.
CEO Lisa Nelson expressed satisfaction with the CBD VaultTM brand's reception, noting its role in gaining traction and visibility in the competitive CBD products market. CBDL aims to leverage this increased visibility to secure stronger sales channel partners, which will drive future sales objectives.
CBD Life Sciences Inc. (OTC PINK:CBDL) has announced the appointment of Jennifer Simmons as the new General Manager. With over 10 years of experience in marketing and business development, Jennifer brings a wealth of expertise to CBDL. Her background includes working with major companies like Square Inc., TNT Fireworks, and Capital One.
In her new role, Jennifer will oversee the opening of multiple retail locations, manage the Scottsdale location, lead the sales team, and drive both in-store and online traffic. Her appointment is expected to significantly boost CBDL's growth, revenue, and marketing strategies.
CBDL, a leading company in the CBD industry, continues to focus on the potential benefits of CBD for various health conditions, including neurological disorders, pain management, and gastrointestinal health.